RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News The Peptide Craze Ground Truths The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York